{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,13]],"date-time":"2026-11-13T23:33:24Z","timestamp":1794612804564,"version":"4.9.1"},"reference-count":37,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"23","license":[{"start":{"date-parts":[[2026,6,5]],"date-time":"2026-06-05T00:00:00Z","timestamp":1780617600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"name":"the Science Foundation of Kangda College of Nanjing Medical University","award":["KD2023KYJJ236"],"award-info":[{"award-number":["KD2023KYJJ236"]}]}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,6,5]]},"abstract":"<jats:sec>\n                    <jats:title\/>\n                    <jats:p>\n                      The objective of this study was to identify risk factors for recurrent cervical high-grade squamous intraepithelial lesions (HSIL\/CIN2-3) following loop electrosurgical excision procedure (LEEP), with a particular focus on evaluating the protective effect of human papillomavirus (HPV) vaccination, including effective timing of administration, against disease recurrence. This retrospective study analyzed 343 patients with colposcopy-directed biopsy-confirmed cervical HSIL who underwent LEEP, including 127 vaccinated and 216 unvaccinated individuals. Multivariate logistic regression analysis was employed to identify risk factors associated with HSIL recurrence. Receiver operating characteristic (ROC) curve analysis was used to determine the optimal cutoff timing of HPV vaccination for preventing post-LEEP HSIL recurrence. Among the 343 patients, the post-LEEP HSIL recurrence rate was 9.0%. Multivariate logistic analysis identified CIN3 (OR\u2005=\u20052.956, 95% CI 1.046\u20138.352,\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      \u2005=\u2005.041), glandular involvement (OR\u2005=\u20053.517, 95% CI 1.165\u201310.621,\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      \u2005=\u2005.026), positive margins (OR\u2005=\u20052.496, 95% CI 1.100\u20135.667,\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      \u2005=\u2005.029), and persistent HPV infection (OR\u2005=\u20056.253, 95% CI 2.043\u201319.135,\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      \u2005=\u2005.001) as independent risk factors for HSIL recurrence. HPV vaccination was associated with a lower risk of HSIL recurrence (OR\u2005=\u20050.249, 95% CI 0.082\u20130.760,\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      \u2005=\u2005.015). ROC analysis indicated that administration of the HPV vaccine within 6 months post-LEEP was the optimal cutoff time for preventing recurrence (AUC\u2005=\u20050.851,\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      = .017). Vaccination either before LEEP or within this 6-month postoperative period significantly reduced the risk of HSIL recurrence (\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      \u2005=\u2005.034). CIN3, gland involvement, positive margins, and persistent HPV infection increase the risk of cervical HSIL recurrence after LEEP. HPV vaccination, when administered either before or within 6 months after LEEP, is associated with a lower risk of cervical HSIL recurrence.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/md.0000000000049167","type":"journal-article","created":{"date-parts":[[2026,6,6]],"date-time":"2026-06-06T04:01:12Z","timestamp":1780718472000},"page":"e49167","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":1,"title":["Effect of prophylactic HPV vaccination and timing of administration on recurrence of cervical HSIL after LEEP: A retrospective study"],"prefix":"10.1097","volume":"105","author":[{"ORCID":"https:\/\/orcid.org\/0009-0006-5448-1614","authenticated-orcid":false,"given":"Lianhua","family":"Liu","sequence":"first","affiliation":[{"name":"Department of Obstetrics and Gynecology, the Affiliated Jiangning Hospital of Nanjing Medical University, Nanjing, China"},{"name":"Jiangning Clinical Medical School, Kangda College of Nanjing Medical University, Nanjing, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-8285-7669","authenticated-orcid":false,"given":"Ningxin","family":"Chen","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, the Affiliated Jiangning Hospital of Nanjing Medical University, Nanjing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qian","family":"Zhu","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, the Affiliated Jiangning Hospital of Nanjing Medical University, Nanjing, China"},{"name":"Jiangning Clinical Medical School, Kangda College of Nanjing Medical University, Nanjing, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7879-3352","authenticated-orcid":false,"given":"Qiaoling","family":"Liu","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, the Affiliated Jiangning Hospital of Nanjing Medical University, Nanjing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20260711","first-page":"229","article-title":"Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries.","volume":"74","author":"Bray","year":"2024","journal-title":"CA Cancer J Clin"},{"key":"R2-20260711","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1097\/LGT.0000000000000525","article-title":"2019 ASCCP risk-based management consensus guidelines for abnormal cervical cancer screening tests and cancer precursors.","volume":"24","author":"Perkins","year":"2020","journal-title":"J Low Genit Tract Dis"},{"key":"R3-20260711","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.ejogrb.2024.06.030","article-title":"Treatment characteristics, HPV genotype distribution and risk of subsequent disease among women with high-grade cervical intraepithelial neoplasia in Europe: a systematic literature review.","volume":"300","author":"Reuschenbach","year":"2024","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"R4-20260711","first-page":"9365654","article-title":"HPV E6\/E7, hTERT, and Ki67 mRNA RT-qPCR assay for detecting high-grade cervical lesion with microscope slides.","volume":"2019","author":"Kim","year":"2019","journal-title":"Anal Cell Pathol (Amst)"},{"key":"R5-20260711","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1111\/cas.14682","article-title":"Human papillomavirus vaccine to prevent cervical intraepithelial neoplasia in Japan: a nationwide case-control study.","volume":"112","author":"Ikeda","year":"2021","journal-title":"Cancer Sci"},{"key":"R6-20260711","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1136\/sextrans-2023-055793","article-title":"Timing of HPV vaccination as adjuvant treatment of CIN2+ recurrence in women undergoing surgical excision: a meta-analysis and meta-regression.","volume":"99","author":"Petr\u00e1\u0161","year":"2023","journal-title":"Sex Transm Infect"},{"key":"R7-20260711","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1097\/CEJ.0000000000000475","article-title":"Nomogram-based prediction of cervical dysplasia persistence\/recurrence.","volume":"28","author":"Bogani","year":"2019","journal-title":"Eur J Cancer Prev"},{"key":"R8-20260711","doi-asserted-by":"crossref","first-page":"253.e1","DOI":"10.1016\/j.ajog.2019.09.039","article-title":"Colposcopic and histopathologic evaluation of women with HPV persistence exiting an organized screening program.","volume":"222","author":"Sahlgren","year":"2020","journal-title":"Am J Obstet Gynecol"},{"key":"R9-20260711","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/S0140-6736(19)30298-3","article-title":"Population-level impact and herd effects following the introduction of human papillomavirus vaccination programmes: updated systematic review and meta-analysis.","volume":"394","author":"Drolet","year":"2019","journal-title":"Lancet"},{"key":"R10-20260711","doi-asserted-by":"crossref","first-page":"l1161","DOI":"10.1136\/bmj.l1161","article-title":"Prevalence of cervical disease at age 20 after immunisation with bivalent HPV vaccine at age 12-13 in Scotland: retrospective population study.","volume":"365","author":"Palmer","year":"2019","journal-title":"BMJ"},{"key":"R11-20260711","doi-asserted-by":"crossref","first-page":"e077341","DOI":"10.1136\/bmj-2023-077341","article-title":"Effect of the HPV vaccination programme on incidence of cervical cancer and grade 3 cervical intraepithelial neoplasia by socioeconomic deprivation in England: population based observational study.","volume":"385","author":"Falcaro","year":"2024","journal-title":"BMJ"},{"key":"R12-20260711","doi-asserted-by":"crossref","first-page":"212.e1","DOI":"10.1016\/j.ajog.2016.02.021","article-title":"Impact of human papillomavirus (HPV) 16 and 18 vaccination on prevalent infections and rates of cervical lesions after excisional treatment.","volume":"215","author":"Hildesheim","year":"2016","journal-title":"Am J Obstet Gynecol"},{"key":"R13-20260711","doi-asserted-by":"crossref","first-page":"245","DOI":"10.3390\/vaccines8020245","article-title":"HPV vaccination as adjuvant to conization in women with cervical intraepithelial neoplasia: a study under real-life conditions.","volume":"8","author":"Del Pino","year":"2020","journal-title":"Vaccines (Basel)"},{"key":"R14-20260711","doi-asserted-by":"crossref","first-page":"6402","DOI":"10.1016\/j.vaccine.2020.07.055","article-title":"Prophylactic HPV vaccination after conization: a systematic review and meta-analysis.","volume":"38","author":"Jentschke","year":"2020","journal-title":"Vaccine"},{"key":"R15-20260711","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1002\/ijc.30623","article-title":"Patterns of persistent HPV infection after treatment for cervical intraepithelial neoplasia (CIN): a systematic review.","volume":"141","author":"Hoffman","year":"2017","journal-title":"Int J Cancer"},{"key":"R16-20260711","doi-asserted-by":"crossref","first-page":"100177","DOI":"10.1016\/j.pvr.2019.100177","article-title":"Is one dose of human papillomavirus vaccine as effective as three?: a national cohort analysis.","volume":"8","author":"Brotherton","year":"2019","journal-title":"Papillomavirus Res"},{"key":"R17-20260711","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1093\/infdis\/jiz555","article-title":"Human papillomavirus vaccine effectiveness against HPV infection: evaluation of one, two, and three doses.","volume":"221","author":"Markowitz","year":"2020","journal-title":"J Infect Dis"},{"key":"R18-20260711","doi-asserted-by":"crossref","first-page":"EVIDoa2100056","DOI":"10.1056\/EVIDoa2100056","article-title":"Efficacy of single-dose HPV vaccination among young African women.","volume":"1","author":"Barnabas","year":"2022","journal-title":"NEJM Evid"},{"key":"R19-20260711","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1136\/ijgc-2023-004275","article-title":"Human papillomavirus (HPV) vaccination: a call for action in Italy.","volume":"33","author":"Bogani","year":"2023","journal-title":"Int J Gynecol Cancer"},{"key":"R20-20260711","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1186\/s12957-023-03088-5","article-title":"Analysis of outcomes following loop electrosurgical excision and clinical features of patients with cervical high-grade squamous intraepithelial lesions with abnormal preoperative endocervical curettage.","volume":"21","author":"Feng","year":"2023","journal-title":"World J Surg Oncol"},{"key":"R21-20260711","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.ejogrb.2023.04.014","article-title":"The efficacy of human papillomavirus prophylactic vaccination after conization in preventing cervical intraepithelial neoplasia recurrence: a prospective observational study in China.","volume":"286","author":"Chen","year":"2023","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"R22-20260711","doi-asserted-by":"crossref","first-page":"698","DOI":"10.3390\/vaccines11030698","article-title":"Outcomes of high-grade cervical dysplasia with positive margins and HPV persistence after cervical conization.","volume":"11","author":"Giannini","year":"2023","journal-title":"Vaccines (Basel)"},{"key":"R23-20260711","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1186\/s12985-023-02001-6","article-title":"Evaluation of the clinical efficacy of vaginal treatment options for persistent high-risk human papillomavirus infection after excisional treatment of cervical high-grade squamous intraepithelial lesions: a systematic review and Bayesian network meta-analysis.","volume":"20","author":"Tang","year":"2023","journal-title":"Virol J"},{"key":"R24-20260711","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1097\/LGT.0000000000000803","article-title":"Performance of different follow-up strategies and genotype-based recurrence risk after treatment of cervical high-grade squamous intraepithelial lesion.","volume":"28","author":"Gra\u00e7a","year":"2024","journal-title":"J Low Genit Tract Dis"},{"key":"R25-20260711","doi-asserted-by":"crossref","first-page":"e42759","DOI":"10.1097\/MD.0000000000042759","article-title":"Development of a nomogram for predicting positive margins after cold knife conization in patients with high-grade squamous intraepithelial lesions.","volume":"104","author":"Wang","year":"2025","journal-title":"Medicine (Baltimore)"},{"key":"R26-20260711","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1016\/j.ygyno.2020.08.025","article-title":"Recurrence rate after loop electrosurgical excision procedure (LEEP) and laser conization: a 5-year follow-up study.","volume":"159","author":"Bogani","year":"2020","journal-title":"Gynecol Oncol"},{"key":"R27-20260711","doi-asserted-by":"crossref","first-page":"1762","DOI":"10.21037\/tcr-22-1466","article-title":"Relationship between positive margin and residual\/recurrence after excision of cervical intraepithelial neoplasia: a systematic review and meta-analysis.","volume":"11","author":"Feng","year":"2022","journal-title":"Transl Cancer Res"},{"key":"R28-20260711","doi-asserted-by":"crossref","first-page":"9087","DOI":"10.2147\/JIR.S494622","article-title":"Prognostic prediction for recurrent\/residual CIN in HSIL patients after conization: an updated retrospective study based on ambulatory surgery.","volume":"17","author":"Huang","year":"2024","journal-title":"J Inflamm Res"},{"key":"R29-20260711","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/LGT.0000000000000708","article-title":"Recurrence in cervical high-grade squamous intraepithelial lesion: the role of the excised endocervical canal length-analysis of 2,427 patients.","volume":"27","author":"Foggiatto","year":"2023","journal-title":"J Low Genit Tract Dis"},{"key":"R30-20260711","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.ygyno.2018.08.033","article-title":"SPERANZA project: HPV vaccination after treatment for CIN2.","volume":"151","author":"Ghelardi","year":"2018","journal-title":"Gynecol Oncol"},{"key":"R31-20260711","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1097\/LGT.0000000000000625","article-title":"Efficacy of human papillomavirus vaccination 4 years after conization for high-grade cervical neoplasia.","volume":"25","author":"G\u00f3mez de la Rosa","year":"2021","journal-title":"J Low Genit Tract Dis"},{"key":"R32-20260711","doi-asserted-by":"crossref","first-page":"288","DOI":"10.3390\/vaccines10020288","article-title":"Effectiveness of prophylactic human papillomavirus vaccine in the prevention of recurrence in women conized for HSIL\/CIN 2-3: the VENUS study.","volume":"10","author":"Casajuana-P\u00e9rez","year":"2022","journal-title":"Vaccines (Basel)"},{"key":"R33-20260711","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1186\/s13027-023-00547-2","article-title":"Can prophylactic HPV vaccination reduce the recurrence of cervical lesions after surgery? Review and prospect.","volume":"18","author":"Han","year":"2023","journal-title":"Infect Agent Cancer"},{"key":"R34-20260711","doi-asserted-by":"crossref","first-page":"887","DOI":"10.3390\/vaccines10060887","article-title":"HPV vaccination in women with cervical intraepithelial neoplasia undergoing excisional treatment: insights into unsolved questions.","volume":"10","author":"Henere","year":"2022","journal-title":"Vaccines (Basel)"},{"key":"R35-20260711","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1002\/ijc.32752","article-title":"Risk of cervical intraepithelial neoplasia grade 2 or worse after conization in relation to HPV vaccination status.","volume":"147","author":"Sand","year":"2020","journal-title":"Int J Cancer"},{"key":"R36-20260711","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.ejogrb.2021.11.008","article-title":"If prophylactic HPV vaccination is considered in a woman with CIN2+, what is the value and should it be given before or after the surgical treatment?","volume":"269","author":"Tjalma","year":"2022","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"R37-20260711","doi-asserted-by":"crossref","first-page":"717","DOI":"10.3390\/vaccines8040717","article-title":"Assessing the long-term role of vaccination against HPV after Loop Electrosurgical Excision Procedure (LEEP): a propensity-score matched comparison.","volume":"8","author":"Bogani","year":"2020","journal-title":"Vaccines (Basel)"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000049167","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,11]],"date-time":"2026-07-11T14:01:27Z","timestamp":1783778487000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000049167"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,5]]},"references-count":37,"journal-issue":{"issue":"23","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000049167","relation":{},"ISSN":["0025-7974","1536-5964"],"issn-type":[{"value":"0025-7974","type":"print"},{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,5]]},"assertion":[{"value":"2025-12-19","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-05-15","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}